Reconstruction and functional analysis of altered molecular pathways in human atherosclerotic arteries

Stefano Cagnin1, Michele Biscuola, Cristina Patuzzo

  • 1CRIBI Biotechnology Centre, University of Padova, Padova, Italy. stefanoc@cribi.unipd.it

BMC Genomics
|January 13, 2009
PubMed

Insights

Atherosclerosis involves inflammation and specific gene pathways like JAK/STAT. This study identifies key genes and proteins, such as S100A9/S100A8 and caveolae system components, crucial for vascular disease progression.

Area of Science:

  • Cardiovascular Biology
  • Molecular Medicine
  • Genomics

Background:

  • Atherosclerosis commonly affects major arteries, with circulating factors potentially mediating plaque rupture and thrombosis.
  • Understanding common molecular pathways is crucial for addressing this widespread vascular disease.

Purpose of the Study:

  • To investigate how calcified plaque presence alters gene expression in human coronary and carotid arteries.
  • To identify atherogenic genes and their functional networks involved in vascular disease.

Main Methods:

  • Utilized DNA microarrays and meta-analysis to compare gene expression in atherosclerotic plaques.
  • Analyzed plasma levels of cytokines, chemokines, and growth factors in patients.

Main Results:

  • Identified key atherogenic genes and functional networks, including caveolae, JAK/STAT pathways, and S100A9/S100A8 proteins.
  • Found elevated levels of various cytokines (e.g., IL-6, VEGF) and chemokines in atherosclerotic patients' plasma.
  • Demonstrated connections between caveolae, hormone receptors, and apoptosis pathways.

Conclusions:

  • Atherosclerosis is characterized as a proinflammatory disorder due to cytokine and S100A9/S100A8 up-regulation.
  • JAK/STAT pathway activation is confirmed by gene up-regulation in plaques.
  • STAT proteins and the caveolae system play central roles in plaque preservation, with Cav-1 impacting SMC differentiation and lipid homeostasis.
Abstract

Related Concept Videos

Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...